aspirin has been researched along with ximelagatran in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 30 (85.71) | 29.6817 |
| 2010's | 5 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Connolly, SJ | 1 |
| Cullberg, M; Eriksson, UG; Eriksson-Lepkowska, M; Fager, G; Frison, L | 1 |
| Bylock, A; Emanuelsson, H; Goodvin, A; Nyström, P; Wallentin, L; Weaver, WD; Wilcox, RG | 1 |
| Clark, AL; Cleland, JG; Coletta, AP; Freemantle, N; Loh, H; Memon, A | 1 |
| Cooper, HA | 1 |
| Finsterer, J; Stöllberger, C | 1 |
| Casas, JP; Hingorani, AD; MacAllister, R | 1 |
| Uchiyama, S | 1 |
| Anderson, M; Kirk, M | 1 |
| Eikelboom, JW; Hankey, GJ | 1 |
| Economides Muñoz, C; Singh, BN | 1 |
| Vadivelu, MK | 1 |
| Waldo, AL | 1 |
| Granger, CB; Weaver, WD | 1 |
| Kiechl, S | 1 |
| Gage, BF; O'Brien, CL | 1 |
| Chauhan, A; Katira, R; More, RS | 1 |
| Edwards, SJ; Lip, GY | 1 |
| Meyer Samama, M | 1 |
| Boccara, F; Cohen, A; Ederhy, S; Hammoudi, N; Janower, S; Meuleman, C | 1 |
| Verheugt, FW | 1 |
| Cheng, TO | 1 |
| Badimon, JJ; Bylock, A; Elg, M; Eriksson, UG; Eriksson-Lepkowska, M; Kalies, I; Nyström, P; Sarich, TC; Wåhlander, K | 1 |
| Cooper, NJ; Khunti, K; Lu, G; Sutton, AJ | 1 |
| Chaparro, S; Connolly, SJ; Flaker, GC; Goldman, S; Gruber, M; Halinen, MO; Halperin, JL; Horrow, J; Vahanian, A | 1 |
| Akins, PT; Albers, GW; Diener, HC; Feldman, HA; Newman, D; Spitzer, SG; Zoble, RG | 1 |
| Agnelli, G; Andersson, M; Bylock, A; Cohen, AT; Dahl, OE; Eriksson, BI; Mouret, P; Ogren, M; Panfilov, S; Rosencher, N | 1 |
| Bylock, A; Emanuelsson, H; Frison, L; Held, P; Oldgren, J; Tangelder, MJ; Weaver, D; Wilcox, RG | 1 |
| Go, G; Gonzalez Della Valle, A; Lyman, S; Salvati, EA; Sharrock, NE | 1 |
| Ezekowitz, M; Lee, R; Nagarakanti, R; Sodhi, S | 1 |
| Christersson, C; Oldgren, J; Siegbahn, A; Wallentin, L | 1 |
| Agarwal, S; Hachamovitch, R; Menon, V | 1 |
16 review(s) available for aspirin and ximelagatran
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Preventing stroke in patients with atrial fibrillation: current treatments and new concepts.
Topics: Aspirin; Atrial Appendage; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Prodrugs; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2003 |
Trials of newer approaches to anticoagulation in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Thrombin; Ticlopidine; Warfarin | 2004 |
[EBM of cerebral infarction: message from mega-studies].
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Cerebral Infarction; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Secondary Prevention; Ticlopidine; Warfarin | 2003 |
Antithrombotic therapies for stroke prevention in atrial fibrillation.
Topics: Aged; Ambulatory Care Facilities; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Cerebral Hemorrhage; Drug Design; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Self Care; Stroke; Thrombin; Warfarin | 2004 |
New possibilities in anticoagulant management of atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Humans; Oligosaccharides; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Warfarin | 2004 |
Reducing cardiac events after acute coronary syndromes.
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic | 2004 |
Direct thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Chemical and Drug Induced Liver Injury; Clinical Trials, Phase III as Topic; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thrombin; Thromboembolism; Warfarin | 2005 |
Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clinical Trials as Topic; Comorbidity; Drug Combinations; Humans; Stroke; Treatment Outcome; Warfarin | 2006 |
[The new antithrombotic agents].
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Azetidines; Benzylamines; Clopidogrel; Fibrinolytic Agents; Glycine; Hirudins; Humans; Injections, Subcutaneous; Platelet Aggregation Inhibitors; Polysaccharides; Prodrugs; Randomized Controlled Trials as Topic; Stents; Thrombosis; Ticlopidine; Time Factors; Venous Thrombosis | 2005 |
[Preventing cerebrovascular accidents during atrial fibrillation].
Topics: Administration, Oral; Age Factors; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Drug Therapy, Combination; Electric Countershock; Humans; Hypolipidemic Agents; Incidence; Injections, Subcutaneous; Middle Aged; Oligosaccharides; Placebos; Platelet Aggregation Inhibitors; Prevalence; Prodrugs; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Stroke; Ticlopidine; Warfarin | 2005 |
New anticoagulants in ischemic heart disease.
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Cerebral Hemorrhage; Coronary Thrombosis; Drug Therapy, Combination; Factor Xa; Fibrinolytic Agents; Follow-Up Studies; Forecasting; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Injections, Intravenous; Injections, Subcutaneous; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Treatment Outcome | 2005 |
Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Drug Therapy, Combination; Humans; Incidence; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Retrospective Studies; Stroke; Treatment Outcome; Warfarin | 2006 |
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.
Topics: Anesthesia, Conduction; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Azetidines; Benzylamines; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression Devices; Morpholines; Platelet Aggregation Inhibitors; Polysaccharides; Pulmonary Embolism; Risk Assessment; Risk Factors; Rivaroxaban; Thiophenes; Treatment Outcome; Warfarin | 2008 |
Chronic antithrombotic therapy in post-myocardial infarction patients.
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Clopidogrel; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Activation; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Thrombolytic Therapy; Thrombosis; Ticlopidine; Vitamin K; Warfarin | 2008 |
Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Brain Ischemia; Clopidogrel; Female; Humans; Incidence; Male; Oligosaccharides; Primary Prevention; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Stroke; Ticlopidine; Treatment Outcome; United States; Warfarin | 2012 |
6 trial(s) available for aspirin and ximelagatran
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, are not influenced by acetylsalicylic acid.
Topics: Administration, Oral; Adult; Aspirin; Azetidines; Benzylamines; Blood Coagulation; Cross-Over Studies; Double-Blind Method; Drug Interactions; Glycine; Humans; Infusions, Intravenous; Male; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Prodrugs; Thrombin; Whole Blood Coagulation Time | 2003 |
Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial.
Topics: Administration, Oral; Aged; Aspirin; Azetidines; Benzylamines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Placebos; Prodrugs; Secondary Prevention; Treatment Outcome | 2003 |
Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.
Topics: Administration, Oral; Adult; Anticoagulants; Arteries; Aspirin; Azetidines; Benzylamines; Bleeding Time; Blood Coagulation; Clopidogrel; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin; Thrombosis; Ticlopidine | 2006 |
Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthroplasty; Aspirin; Azetidines; Benzylamines; Bleeding Time; Blood Loss, Surgical; Blood Transfusion; Double-Blind Method; Enoxaparin; Europe; Female; Humans; Lower Extremity; Male; Middle Aged; Platelet Aggregation Inhibitors; South Africa; Thrombosis | 2006 |
Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) tri
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Treatment Outcome | 2008 |
Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarction.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antithrombins; Aspirin; Azetidines; Benzylamines; Biomarkers; Blood Platelets; C-Reactive Protein; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Inflammation; Interleukin-10; Interleukin-18; Male; Middle Aged; Myocardial Infarction; P-Selectin; Platelet Activation; Risk Factors; Thromboplastin; Time Factors; Treatment Outcome | 2011 |
13 other study(ies) available for aspirin and ximelagatran
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Clinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEM.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Azetidines; Benzimidazoles; Benzylamines; Biphenyl Compounds; Coronary Disease; Europe; Heart Failure; Humans; Natriuretic Peptide, Brain; Perindopril; Prodrugs; Randomized Controlled Trials as Topic; Tetrazoles | 2003 |
Ximelagatran or warfarin in atrial fibrillation?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Drug Therapy, Combination; Humans; Prodrugs; Randomized Controlled Trials as Topic; Stroke; Thromboembolism; Treatment Outcome; Vitamin K; Warfarin | 2004 |
Ximelagatran or warfarin in atrial fibrillation?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Humans; Randomized Controlled Trials as Topic; Research Design; Stroke; Thromboembolism; Treatment Outcome; Warfarin | 2004 |
Anticoagulation in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Electric Countershock; Fibrinolytic Agents; Humans; Prodrugs; Stroke; Warfarin | 2004 |
The beginning of the end of warfarin?
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Glycine; Humans; Platelet Aggregation Inhibitors; Prodrugs; Thrombin; Warfarin | 2004 |
Aspirin bias in SPORTIF III trial.
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Humans; Platelet Aggregation Inhibitors; Prodrugs; Randomized Controlled Trials as Topic; Selection Bias; Stroke; Thrombin; Warfarin | 2004 |
[Stroke prevention in atrial fibrillation -- transfer of study results to the practice].
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clinical Trials as Topic; Cohort Studies; Contraindications; Humans; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Recurrence; Risk Factors; Stroke; Time Factors | 2004 |
Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Chronic Disease; Cost-Benefit Analysis; Decision Support Techniques; Humans; Prodrugs; Quality-Adjusted Life Years; Stroke; United States; Warfarin | 2005 |
Food-drug interactions.
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Calcium Channel Blockers; Food Additives; Food-Drug Interactions; Honey; Humans; Soy Foods | 2006 |
Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Drug Therapy, Combination; Embolism; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Treatment Outcome; Warfarin | 2006 |
Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Drug Therapy, Combination; Female; Humans; Male; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Stroke; Warfarin | 2007 |